A core team of experts in the fields of biomarker and thrombosis research, clinical cardiology, immunotherapy, epidemiology and machine learning has come together to establish the cluster. With their complementary expertise and access to extensive population studies (Gutenberg Health Study) and disease cohorts, the curATime core partners, consisting of TRON gGmbH, the University Medical Center of the Johannes Gutenberg University Mainz and the German Research Center for Artificial Intelligence (DFKI) in Kaiserslautern, have excellent prerequisites for achieving the ambitious cluster goals and thus the therapy for combating atherothrombosis that is targeted at the individual patient.

Prof. Dr. Johnny Kim - Cluster spokesman

Prof. Dr. Johnny Kim, Head of the Department for Cardiovascular Therapeutics at TRON, uses systems biology approaches to study the molecular mechanisms of cell differentiation processes and their reversal. He is a recognised expert in the field of tissue regeneration, stem cell, developmental and reprogramming biology. Johnny is associated with the German Centre for Cardiovascular Research (DZHK) at its Rhein-Main location and Associated Professor (Adjunct) at Yale University in New Haven, USA.

Priv.-Doz. Dr. Boris Strilic - Deputy cluster spokesman

Priv.-Doz. Dr. Boris Strilic is Deputy Head of the Department of Cardiovascular Therapeutics at TRON. He has many years of experience in molecular medicine, particularly in the field of vascular research. Dr. Strilic shares his extensive expertise in vascular cell biology by teaching at the Goethe University Frankfurt.

Dr. Tina Büchling - Administrative coordinator

Dr. Tina Büchling, head of TRONs project and collaboration management, is responsible for external and internal communication. With her as administrative coordinator, curATime will benefit from many years of expertise in agile project management in academic as well as industrial settings. She was already significantly involved in the administrative management of the scientific excellence cluster Ci3 in Mainz.

Univ.-Prof. Dr. med. Ugur Sahin

Univ.-Prof. Dr. med. Ugur Sahin, Professor of Translational Oncology and Immunology at the University Medical Center of the Johannes Gutenberg University Mainz (UM) is a co-founder and scientific advisor of TRON gGmbH and CEO of BioNTechSE. He is an internationally distinguished expert in the field of mRNA technology. He focuses his current research activities on novel immunotherapeutic targets and the development of individualized treatment approaches as well as innovative immunotherapies.

Overview of publications

Univ.-Prof. Dr. Andreas Dengel

Univ.-Prof. Dr. Prof. h.c. Andreas Dengel, Executive Director of the Deutsches Forschungszentrum für Künstliche Intelligenz GmbH (DFKI) in Kaiserslautern, Head of the Research Area Smart Data and Knowledge Services and Professor at the Department of Computer Science at the RPTU Kaiserslautern-Landau is an internationally distinguished AI expert. As a member of the Biotechnology Advisory Board RLP (https://biotech.rlp.de/de/koordinator-beirat/), Prof. Dengel is contributing his many years of experience in AI-based analysis of multi-omics data and medical images as well as on explainable AI to curATime.

Overview of publications

Univ.-Prof. Dr. med. Wolfram Ruf

Univ.-Prof. Dr. Wolfram Ruf, Scientific Director and Spokesman of the Centre for Thrombosis and Haemostasis Mainz (CTH), specializes in translational thrombosis research, coagulation factors and their signal transduction in tumour progression, as well as autoimmunity, atherosclerosis and angiogenesis. He is Deputy Spokesman of the Translational Vascular Biology Center Research Center as well as Principle Investigator at the German Center for Cardiovascular Research (DZHK).

Overview of publications

Univ.-Prof. Dr. med. Philipp Wild

Univ.-Prof. Dr. med. Philipp Wild is W3 Professor at the University Medical Center Mainz and heads the departments of Clinical Epidemiology and Systems Medicine at the Center for Thrombosis and Haemostasis as well as the department of Preventive Cardiology and Medical Prevention at the Center for Cardiology. He is a recognized expert in the field of translational research on common diseases, especially cardiovascular diseases. His focus lies on a medical systems research approach with multi-level data analyses.

Overview of publications